EUVIMEDEUVIMED entdecken
Crossref

Continuous Glucose Monitoring for Pancreatogenic Diabetes After Total Pancreatectomy

Young Jae Cho iD, Inhyuck Lee iD, Yoon Soo Chae, Go-Won Choi iD, Younsoo Seo, Youngmin Han, Hye-Sol Jung iD, Wooil Kwon, Joon Seong Park, Jin-Young Jang iD

Journal of Hepato-Biliary-Pancreatic Sciences · 2025

DOI: 10.1002/jhbp.70050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Young Jae Cho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Pancreatectomy, Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Continuous glucose monitoring (CGM) is increasingly used for glycemic control, but its role after total pancreatectomy (TP) in pancreatogenic diabetes mellitus (PDM) is understudied. This study evaluated postoperative CGM utility in this population.

Methods

Thirty‐seven TP patients (2022–2024) at Seoul National University Hospital were grouped by CGM use (CGM users = 11) and analyzed for baseline and perioperative diabetes‐related factors. In a preoperative non‐diabetic subgroup ( n = 10, CGM users = 6), pre‐ and postoperative hemoglobin A1c (HbA1c) was compared by CGM use. For consenting CGM users, changes in time in range (TIR), time above range (TAR), and time below range (TBR) from 1 to 3 months postoperatively were analyzed.

Results

CGM users had lower postoperative HbA1c than non‐users overall (6.5% vs. 8.0%; p < 0.001) and in non‐diabetics (6.0% vs. 7.4%; p = 0.002). Among 80% sharing CGM data, TIR increased from 62.6% at 1 month to 71.8% at 3 months ( p = 0.035), TAR decreased from 36.3% to 26.6% ( p = 0.037), and TBR was unchanged.

Conclusions

Proactive CGM use may improve postoperative glycemic management in PDM after TP by increasing awareness of glycemic patterns, resulting in lower HbA1c and greater time in the target range.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatectomyBlood GlucoseBlood Glucose Self-MonitoringDiabetes MellitusHumansMaleFemaleMiddle AgedAgedGlycated HemoglobinRetrospective StudiesGlycemic ControlContinuous Glucose Monitoring

Stichwörter der Autor:innen

continuous glucose monitoringdiabetes mellitushyperglycemiapancreatectomy

Substanzen

Blood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Young Jae Cho, Inhyuck Lee, Go-Won Choi, Hye-Sol Jung, Jin-Young Jang

Zitieren

APA

Cho, Y. J., Lee, I., Chae, Y. S., Choi, G. W., Seo, Y., Han, Y., Jung, H. S., Kwon, W., Park, J. S., & Jang, J. Y. (2025). Continuous Glucose Monitoring for Pancreatogenic Diabetes After Total Pancreatectomy. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70050

Vancouver

Cho YJ, Lee I, Chae YS, Choi GW, Seo Y, Han Y, et al. Continuous Glucose Monitoring for Pancreatogenic Diabetes After Total Pancreatectomy. Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.70050

BibTeX
@article{Cho2025,
  author = {Cho, Young Jae and Lee, Inhyuck and Chae, Yoon Soo and Choi, Go-Won and Seo, Younsoo and Han, Youngmin and Jung, Hye-Sol and Kwon, Wooil and Park, Joon Seong and Jang, Jin-Young},
  title = {Continuous Glucose Monitoring for Pancreatogenic Diabetes After Total Pancreatectomy},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2025},
  doi = {10.1002/jhbp.70050}
}
Kostenlos starten →